Overview
This project addresses the problem of adverse drug reactions in the three most frequently prescribed therapeutic classes of drugs in children: antibiotics, analgesics, and mental health medications.
We will conduct pilot testing of a pharmacogenomic testing panel and study how the tests and generated test results are utilized and understood by physicians, pharmacists, patients and their families.
Description
The specific objectives are to:
- Implement a pilot pharmacogenomics program to test medication safety and effectiveness of antibiotics, analgesics and mental health medication to enhance prescribing decision-making.
- Develop data collection forms to collect necessary patient information from the prescribing physicians.
- Develop pharmacogenomics reports to return results to physicians, pharmacists, patients and their families.
- Determine how the tests and results are perceived and utilized by physicians, pharmacists, patients and their families.
Eligibility
Inclusion Criteria:
- Participants will be enrolled if they can benefit from pharmacogenomic testing. This means their physician is considering the use of a drug that is part of the panels (analgesics, antibiotics, and mental health medication) or they are already using one.
Exclusion Criteria:
- Patients who do not speak or understand English.